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The efficient receptor-mediated targeting of soluble lyso-
somal proteins to lysosomes requires the modification
with mannose 6-phosphate (M6P) residues. Although the
absence of M6P results in misrouting and hypersecretion
of lysosomal enzymes in many cells, normal levels of
lysosomal enzymes have been reported in liver of patients
lacking the M6P-generating phosphotransferase (PT). The
identity of lysosomal proteins depending on M6P has not
yet been comprehensively analyzed. In this study we pu-
rified lysosomes from liver of PT-defective mice and 67
known soluble lysosomal proteins were identified that
illustrated quantitative changes using an ion mobility-as-
sisted data-independent label-free LC-MS approach. Af-
ter validation of various differentially expressed lysosomal
components by Western blotting and enzyme activity as-
says, the data revealed a small number of lysosomal pro-
teins depending on M6P, including neuraminidase 1, ca-
thepsin F, Npc2, and cathepsin L, whereas the majority
reach lysosomes by alternative pathways. These data
were compared with findings on cultured hepatocytes
and liver sinusoid endothelial cells isolated from the liver
of wild-type and PT-defective mice. Our findings show
that the relative expression, targeting efficiency and lys-
osomal localization of lysosomal proteins tested in cul-
tured hepatic cells resemble their proportion in isolated
liver lysosomes. Hypersecretion of newly synthesized non-
phosphorylated lysosomal proteins suggest that secretion-
recapture mechanisms contribute to maintain major lyso-
somal functions in liver. Molecular & Cellular Proteomics
16: 10.1074/mcp.M116.063636, 438–450, 2017.
Soluble lysosomal proteins undergo a specific modification
on high-mannose type N-linked oligosaccharides for an effi-
cient transport from the Golgi apparatus to late endosomes
and lysosomes by phosphorylation of distinct mannose resi-
dues in the C6 position. This modification is catalyzed by the
subsequent action of two enzymes: the first enzyme is an
N-acetylglucosamine (GlcNAc)1-1-phosphotransferase (PT),
which mediates the transfer of GlcNAc-1-phosphate from
uridine diphosphate (UDP)-GlcNAc to mannose acceptors
forming GlcNAc-phosphomannose diester (1–3). The second
so called ‘uncovering enzyme’ removes GlcNAc to expose
mannose 6-phosphate (M6P) residues (4). Two M6P-specific
receptors (MPRs), MPR46 and MPR300, can bind M6P-mod-
ified lysosomal proteins in the trans Golgi network (TGN) and
mediate their segregation from the secretory pathway (5).
Lysosomal enzymes which escape the binding to MPRs are
secreted but can be reinternalized by MPR300 localized at the
plasma membrane and delivered to lysosomes via the endo-
cytic pathway. MPR-ligand complexes reach late endosomal
compartments where the acidic pH induces the dissociation of
lysosomal cargo. MPRs are then transported back to the TGN
or the plasma membrane for further rounds of transport (6).
PT is a heterohexameric enzyme complex consisting of two
, two , and two  subunits (7). The - and -subunits are
encoded by the GNPTAB gene (8, 9), and the -subunits are
coded by GNPTG (10). The - and -subunits contain the
catalytic center for PT activity and the recognition sites for
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lysosomal protein substrates and UDP-GlcNAc (11) whereas
the role of the -subunits are less defined, but might be
involved in the folding and stabilization of the PT complex,
prerequisite for optimum catalytic activity, and selective rec-
ognition of subsets of lysosomal proteins (12, 13). Mutations
in GNPTAB and GNPTG lead to lysosomal storage diseases,
mucolipidosis type II (ML II also called I-cell disease) and III
(ML III) (14). The failure or partial formation of M6P residues on
soluble lysosomal proteins in ML II and ML III, respectively,
impair their proper delivery to lysosomes and result in their
hypersecretion into the extracellular space and bloodstream.
The defect in mannose phosphorylation, however, allows
processing of high mannose-type oligosaccharides to nega-
tively charged complex-type units and the formation of ab-
normal proteolytically processed intracellular and secreted
forms of lysosomal enzymes (15–17). Although all cells and
tissues in ML II are deficient in PT activity, fibroblast and
mesenchymal cells are most strikingly affected (18), indicating
that these cells particularly rely on M6P-dependent lysosomal
protein delivery pathways. In contrast, many cell types (such
as hepatocytes, Kupffer cells and leukocytes) and several
organs (liver, spleen, kidney and brain) have nearly normal
level of lysosomal enzymes (18–21). These observations sug-
gest the existence of lysosomal transport pathways that do
not require M6P recognition marker on lysosomal enzymes.
We have generated previously a Gnptab knock-in (PTki)
mouse model for ML II by insertion a mutation found in ML II
patients which led to a complete loss of PT activity (17). These
PTki mice show all biochemical and clinical symptoms of the
human disease (17, 22, 23). Here we present a comprehensive
quantitative proteomic approach of purified lysosomes (“tri-
tosomes”) from liver of wild-type (wt) and PTki mice. This
allowed us to identify proteins for which M6P is indispensable
for their proper delivery to lysosomes. We found proteins
which are significantly decreased, as well as sets of proteins
of similar or even increased expression in lysosomes from
PTki mice in comparison with wild-type controls. The analytic
data were biochemically evaluated and compared with pri-
mary cultured hepatocytes and sinusoid endothelial cells
(LSECs). Further, pulse-chase experiments with cultured he-
patic cells indicated that hypersecretion of nonphosphory-
lated lysosomal enzymes followed by M6P-independent re-
capture mechanisms are important for maintenance of
lysosomal functions in ML II liver.
EXPERIMENTAL PROCEDURES
Antibodies and Materials—The Npc2 antiserum was a kind gift from
Dr. Shutish Patel and described previously (24), Neu1 and Ppca
antibodies were a kind gift from Dr. Allessandra D’Azzo (St. Jude
Children’s Research Hospital; Memphis), Mpr300 antibodies were a
kind gift from Dr. Kurt von Figura (University of Göttingen) and -glu-
curonidase antibody was kindly provided by Dr. William S. Sly (St.
Louis University). Recombinant human arylsulfatase B (ARSB) was
kindly provided by Dr. Michel Vellard (Biomarin/Genzyme, San Rafael,
CA). The monoclonal Lamp1 (clone 1D4B) and Lamp2 (clone Abl93)
antibodies were purchased from the Developmental Studies Hy-
bridoma Bank. Ctsd antiserum used for immunofluorescence analysis
and immunoprecipitation was described previously (25). Antibodies
against Ctsd for Western blotting, Ctsh, Ctsa, and Ctss were obtained
from Santa Cruz (Dallas, TX). Ctsb was purchased from Neuromics,
Ctsz, and Ctsl from R&D Systems (Minneapolis, MN), Lrp1 and Ldlr
from Abcam. Chemicals were, if not stated otherwise, purchased
from Sigma Aldrich (Cambridge, United Kingdom).
Mice—The PTki mouse model was generated by the insertion of a
cytosine in position 3082 of the murine Gnptab gene (c.3082insC)
(17). Mice were housed in a pathogen-free animal facility at the
University Medical Center Hamburg-Eppendorf, and experimental
procedures were performed according to the institutional guidelines
and approved by the Amt für Gesundheit und Verbraucherschutz and
the Ministerium für Landwirtschaft, Umwelt und ländliche Räume des
Landes Schleswig-Holstein.
Isolation of Primary Hepatocytes and Liver Sinusoidal Endothelial
Cells (LSECs)—Primary mouse hepatocytes were isolated by liver
perfusion, EDTA dissociation and centrifugation on a Percoll gradient
as described previously (26). LSECs were isolated as described pre-
viously (27).
Isolation of Lysosomes from Liver (Tritosomes)—Mice were in-
jected with 4 l/g bodyweight of a 17% (w/v in 0.9% NaCl) Triton
WR1339 solution (Sigma Aldrich) 4 days prior to sacrifice. The livers
were removed and homogenized in five volumes of ice-cold 0.25 M
sucrose with three strokes with a Potter-Elvejhem homogenizer. The
homogenates were centrifuged at 1000  g for 10 min at 4 °C. After
removal of the supernatant and resuspension of the pellet followed by
another centrifugation step at 1000  g for 10 min at 4 °C, the
supernatants were pooled (post nuclear supernatant, PNS) and cen-
trifuged in an ultracentrifuge at 56,000  g (70.1 Ti rotor, Beckmann,
Coulter, Indianapolis, IN) for 7 min at 4 °C. After rehomogenization of
the pellet with 0.25 M sucrose followed by another ultracentrifugation
step, the supernatant was discarded and the pellet was resuspended
in sucrose solution with a density of 1.21 (resulting in the ML-fraction,
representing the mitochondrial-lysosomal fraction). The ML fraction
(3.5 ml) was overlaid each with 2.5 ml sucrose solutions of 1.15,
1.14, and finally 1.06 density yielding a discontinuous sucrose
gradient. After centrifugation at 110,000  g for 150 min in a
swinging bucket rotor (SW41 Ti rotor, Beckmann Coulter), lyso-
somes/tritosomes were collected at the interphase between  1.14
and 1.06 sucrose (F2-fraction).
Western Blotting—Five micrograms (tritosome protein), 100 g
(total liver protein), or 25 g hepatocytes or LSECs protein were
separated by SDS-PAGE and blotted on nitrocellulose membranes.
After blocking with low-fat milk powder for 30 min at room tempera-
ture, membranes were incubated with the primary antibodies over
night at 4 °C. After further incubation with Horseradish peroxidase-
coupled secondary antibodies, blots were developed with enhanced
chemiluminescence solution. Densitometric analyses were performed
with the ImageJ software (NIH) to quantify band intensities.
Two-dimensional Gel Electrophoresis—Two-dimensional gel elec-
trophoresis was carried out essentially as described previously (28)
with Immobiline DryStrip gels (IPG strip) (GE Healthcare Life Sciences)
in a pH range of 4–7 and 400 g of total tritosome protein.
Metabolic Labeling and Immunoprecipitation of Cathepsin D and
Z—Cells grown on 35 mm dishes were metabolically labeled with 150
Ci/ml [35S] methionine (Hartmann Analytik; 37 Bq/mmol)in methio-
nine-free DMEM for 45 min. After removal of the radioactive medium,
cells were either harvested or washed with PBS and chased for 5 h in
DMEM containing 5% dialyzed fetal bovine serum (FBS). Cell extracts
and media were analyzed by immunoprecipitation of cathepsin D and
cathepsin Z followed by SDS-PAGE and fluorography (29).
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Endocytosis of Arylsulfatase B (ARSB)—Human ARSB was iodi-
nated with sodium [125I] (Hartmann Analytik, Braunschweig, Germany,
74 TBq/mmol) and IODO-GEN® (Pierce, Waltham, MA) as described
(30) to a specific activity of 22 Ci/g. Hepatocytes grown in 35 mm
dishes were preincubated with DMEM containing 0.1% bovine serum
albumin (BSA) (DMEM/BSA) for 30 min, followed by incubation with
[125I]-labeled ARSB (600,000 cpm/ml in DMEM/BSA) in the absence
or presence of 10 mM M6P or 10 M receptor associated protein
(RAP) for 20 min at 37 °C as indicated. After washing, the cells were
either harvested in 10 mM Tris/HCl, pH 7.4 containing 0.25 M sucrose
or chased for 6 h in DMEM/BSA. The cells were solubilized in PBS
containing 0.2% Triton X-100 and protease inhibitors, separated by
SDS-PAGE and visualized by autoradiography.
Immunofluorescence Staining of Hepatocytes—Double immunoflu-
orescence staining of hepatocytes was performed as described pre-
viously (31). For filipin staining the cells were stained with 1 g/l
filipin in PBS.
Immunofluorescence Staining of Liver Sections—Formalin-fixed
liver was equilibrated in 30% (w/v) sucrose in 0.1 M phosphate buffer
(PB), pH 7.4 overnight and sectioned using a sliding microtome
(SM2000R, Leica) into 30 m thick free floating sections and collected
in PB. After blocking in PB containing 0.5% Triton X-100 and 4%
normal goat serum for 2 h at room temperature, sections were incu-
bated with the primary antibodies in the blocking solution overnight at
4 °C. After washing three times in PB containing 0.25% Triton X-100
(washing solution), sections were incubated with fluorophore-coupled
secondary antibodies (AlexaFluor 488 and 594; Molecular Probes,
Waltham, MA) for one hour at room temperature. After additional
three washing steps in washing solution, sections were coverslipped
in Mowiol/DABCO. Confocal microscopy was performed on an Olym-
pus FV1000 fluorescence microscope.
Enzyme Activity Measurements—Enzyme activity measurements
were performed with liver homogenates, tritosomes, hepatocytes,
and 24 h conditioned media. The liver was homogenized in 5 volumes
of 50 mM Tris/HCl buffer pH 7.4 containing 0.25 M sucrose, 1 mM
EDTA and protease inhibitors (Sigma) and centrifuged at 500  g to
remove all cell debris. After addition of 0.5% Triton X-100 the lysates
were incubated for 1 h at 4 °C. Cultured hepatocytes were extracted
directly in PBS containing 1% Triton X-100 and protease inhibitors.
Activities of -glucuronidase, -L-iduronidase and -L-fucosidase were
measured in 0.1 M sodium citrate buffer pH 4.5 containing 0.15 M NaCl
with 1 mM 4-methylumbelliferyl -D-glucuronide (Sigma-Aldrich), 50
M 4-methylumbelliferyl -L-iduronide (Glycosynth) and 1 mM
4-methylumbelliferyl--L-fucopyranoside (Sigma-Aldrich), respec-
tively. As enzyme source extracts of 50–100 g liver tissue (50–100
g protein), hepatocytes (25–70 g protein), and tritosomes (5 g
protein) were added to the assay mixture to a final volume of 100 l.
After incubation for 2 to 24 h at 37 °C the reaction was stopped by
addition of 900 l 0.4 M glycine/NaOH buffer, pH 10.4.
Measurement of iduronate-2-sulfatase activity was performed as
described previously (32). Using 100 and 5 g protein of liver extracts
and tritosomes, respectively, as enzyme source. The liberated
4-methylumbelliferone was measured fluorometrically (excitation at
355 nm and emission 460 nm) related to 4-MU standard solutions.
Protein Digestion—Each sample (20 g of protein) was dissolved in
0.1% (w/v) RapiGest (Waters Corporation, Milford, MA) in 50 mM
ammonium bicarbonate (Sigma Aldrich, St. Louis, MO) and heated at
80 °C for 45 min. The samples were reduced in the presence of 5 mM
dithiotreitol (Sigma Aldrich) at 60 °C for 30 min and alkylated in the
presence of 10 mM iodoacetamide (Sigma Aldrich) at ambient tem-
perature in the dark for another 30 min. Proteolytic digestion was
initiated by adding sequencing grade TMPK-treated trypsin (Pro-
mega, Madison, MI) at a 1:50 (w/w) ratio and incubation conducted for
4 h at 37 °C. A second aliquot of trypsin was added at a 1:50 (w/w)
ratio and followed by incubation overnight at 37 °C. TFA was added
to a final concentration of 0.5% (v/v) in order to hydrolyze RapiGest
and the solutions incubated at 37 °C for 20 min before being vortexed
and centrifuged for 30 min at 13,000 rpm.
LC-MS Configuration—LC separations were performed with an
ACQUITY M Class system (Waters Corporation), equipped with a
Symmetry C18 5 m, 2 cm  180 m precolumn and an HSS T3 C18
1.7 m, 25 cm  75 m analytical column. The samples were trans-
ferred with aqueous 0.1% (v/v) formic acid to the precolumn at a flow
rate of 5 l/min. Mobile phase A was water containing 0.1% (v/v)
formic acid, whereas mobile phase B was acetonitrile containing
0.1% (v/v) formic acid. The peptides were eluted from the precolumn
to the analytical column and separated with a gradient of 3–40%
mobile phase B over 90 min at a flow rate of 300 nl/min. The analytical
column temperature was maintained at 35 °C. The lock mass com-
pound, [Glu1]-Fibrinopeptide B (200 fmol/l), was delivered at 600
nl/min to the reference sprayer of the mass spectrometer.
Mass spectrometric analysis of tryptic peptides was performed
using a Synapt G2-Si mass spectrometer (Waters Corporation,
Wilmslow, United Kingdom). The mass spectrometer was operated in
v-mode with nominal resolution of 20,000 FWHM. All analyses were
performed in positive mode ESI. The ion source block temperature
and capillary voltage were set to 100 °C and 3.2 kV, respectively. The
time of flight analyzer (ToF) of the mass spectrometer was externally
calibrated with a NaCsI mixture from m/z 50 to 1990. LC-MS data
were collected in mobility assisted data independent (UDMSE) mode
of acquisition (33). The spectral acquisition time in each mode was
0.5 s with a 0.02 s interscan delay. In low energy mode, data were
collected at constant Trap collision energy of 4 eV (per unit charge)
and a constant Transfer collision energy of 2 eV (per unit charge). In
elevated energy mode, the Trap collision energy was ramped from 4
eV to 5 eV (per unit charge) in 0.5 s, and the Transfer collision energy
was set to ramp during each 14 ms ion mobility separation, with the
ramp applying the optimum collision energy for species at a particular
drift time. The ion mobility separations were combined in a 0.5 s total
elevated energy integration time. The reference sprayer sampled ev-
ery 60 s and the data post-acquisition lock mass corrected.
Data Processing and Database Searching—ProteinLynx Global-
SERVER v3.0.2 (Waters Corporation) was used to process the ac-
quired data. Protein identifications were obtained by searching a Mus
Musculus UniProt database (16,674 reviewed entries, release
2014_10). To assess protein and peptide FDR values, decoy database
entries were created by reversing the amino acid sequences and
concatenating them with the original database entries. The principle
of the search algorithm has been described (34). Peptide and frag-
ment ion tolerances were determined automatically, equaling 5 and
10 ppm respectively, one missed cleavage allowed, as well as fixed
carbamidomethylation modification of cysteine and variable oxidation
modification of methionine. ISOQuant was applied for the integrated
quantitative analysis of data derived from multiple LC-MS runs (http://
www.isoquant.net). The results have been deposited to the Proteome
Xchange Consortium (http://proteomecentral.proteomexchange.org)
via the PRIDE partner repository (35) with the data set identifier
PXD001556.
Experimental Design and Statistical Rationale, Statistics, Hierarchi-
cal Clustering, Enrichment Analysis, and Principal Component Anal-
ysis—The experimental design comprised four biological and three
technical replicates of PTki and WT each, a number adequate enough
to detect small changes in the protein abundance in the tritosome
samples with sufficient statistical power. Two-tailed unpaired Stu-
dent‘s t-tests were calculated using Excel (tables) or Graphpad Prism
(graphs). The protein abundance data from WT and PTki mice fol-
lowed a normal distribution. Errors bars represent the means  S.E.
of mean (S.E.). For annotation of proteomics data as heat maps,
Mannose 6-Phosphate-Independent Lysosomal Proteome of Liver
440 Molecular & Cellular Proteomics 16.3
GENE-E software was used (http://www.broadinstitute.org/cancer/
software/GENE-E). Both columns and rows were hierarchically clus-
tered and the “one minus Pearson correlation” was chosen as the
column distance metric. Principal component analysis was performed
by ClustVis (36). For functional annotation of the proteomics data, the
“Database for Annotation, Visualization and Integrated Discovery”
(DAVID) was used and the “Functional Annotation Chart” was chosen
for enrichment-analysis of KEGG pathways (37).
RESULTS
Proteomic Analysis of Isolated Liver Lysosomes—Early
studies measuring the activities of few lysosomal hydrolases
in liver tissue of ML II patients have revealed nearly normal
levels (19, 20). In order to determine the impact of the loss of
M6P targeting signals on the lysosomal proteome in the liver,
Triton WR1339-filled lysosomes (tritosomes) were purified
from the liver of wt and PTki mice by differential and subse-
quent discontinuous sucrose gradient centrifugation (Fig. 1A;
(38)). Western blotting analysis of liver lysates and different
fractions obtained showed highest enrichment of lysosomes
in the F2-fraction characterized by the lysosomal membrane
protein Lamp1. The enrichment and yield of tritosomes were
comparable between wt and PTki preparations (Fig. 1B and
1C). One-dimensional SDS-PAGE and Coomassie Blue stain-
ing of wt and PTki lysosomes, however, revealed significant
differences in intensity and band pattern (Fig. 1D). Separation
of the lysosomal F2 fractions by 2D gel electrophoresis fol-
lowed by Coomassie staining indicated additional differences
in the composition of the lysosomal proteome between wt
and PTki mouse liver, such as the amounts and isoform pat-
tern for lysosomal proteases tripeptidyl peptidase 1 (Tpp1),
cathepsin H (Ctsh), Ctsz, Ctsb, and Ctsd (supplemental Fig.
S1). The altered charges and molecular masses of proteins in
PTki lysosomes are most likely because of differences in com-
plex type oligosaccharides and proteolytic modifications (15,
39). Because 2D gel electrophoresis resolve only the most
abundant lysosomal proteins representing a small part of the
proteome (28), quantitative label-free LC-/MS (ion mobility-
assisted data independent analysis (UDMSE (33)) was applied
to tritosome samples purified from four different animals of
each genotype from distinct littermates. The protein amounts
were estimated by expressing summed peptide intensity re-
sponses versus that of an exogenous protein spike (40), and
normalized, to account for experimental differences, to the
total tritosome protein content and expressed as g/g trito-
some protein values. About 900 proteins have been identified
in the lysosomal F2 fractions of wt and PTki animals, but
among them lysosomal proteins represent half of the most
abundant 150 proteins (supplemental Table S1). The numer-
ous nonlysosomal proteins identified here represent mostly
mitochondrial, cytosolic as well as intermediate filament pro-
teins that we considered as contaminants (supplemental Fig.
S2). However, we cannot exclude that several of these pro-
teins may reach lysosomes via the degradative autophagy
pathway. Hierarchical clustering of the list of selected soluble
lysosomal proteins revealed clear differences in the levels of
most proteins between wt and PTki mice (Fig. 2A). Principal
component analysis (PCA) of the soluble lysosomal proteins
showed a clear separation of the two genotypes (Fig. 2B).
Furthermore, sigmoidal plot of all identified proteins demon-
strated differential protein levels for a number of proteins
including soluble lysosomal enzymes like Neu1 and Ctsf
FIG. 1. Subcellular fractionation and purification of lysosomal fractions for proteomic analysis. A, Schematic diagram of the applied
workflow for subcellular fractionation of lysosomes from mouse liver. B, Representative photographs of the discontinuous sucrose gradients
of mitochondria and lysosome-enriched fractions (ML) from wt and PTki mice. The positions of F1 to F4 fractions of the gradient are indicated.
The F2-fraction (bold) is the lysosome-enriched fraction used for further experiments. C, Western blotting analysis of liver extracts and the
different subcellular fractions (25 g protein) from wt and PTki mouse liver reveal the enrichment of the lysosomal marker protein Lamp1. PNS,
postnuclear supernatant; ML, mitochondria/lysosomes; F2, lysosome-enriched fraction. D, Coomassie Blue stained SDS gel (15% acrylamide)
used to separate each 20 g of lysosomal F2 fraction from two wt and PTki animals. The positions of molecular mass marker proteins in kDa
are indicated.
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which are decreased in PTki mice. Others such as the lyso-
somal membrane proteins Lamp1 and Lamp2 proteins were
unchanged, whereas a number of soluble proteins like Ctsk
and Mpo were found to be increased in PTki mice (Fig. 2C).
Among the identified proteins, 67 soluble lysosomal
proteins described previously were found (41, 42) with the
exception of sulfamidase (Gns), -N-acetylglucosaminidase
(Naglu) and arylsulfatase K (Arsk), whose expression was too
FIG. 2. Global proteomic change analysis of lysosome-enriched fractions from wt and PTki mouse liver. A, Heat map representation
and hierarchical clustering of 67 soluble lysosomal proteins identified and quantified by LC/MSE in at least five out of eight animals. Clustering
of color-coded lysosomal proteins of the individual animals of each genotype is shown. Blue, higher protein amount than wt; red, lower protein
amount than wt. B, Principal component analysis (PCA) of the proteome data analyzed for soluble lysosomal proteins shows clear separation
of the two genotypes (wt1–4, green spots, PTki1–4, blue spots) and the close grouping of the individual animals. Percentage variance for each
principal component is given. C, Sigmoidal plot of all 902 identified proteins shows differential protein levels for a number of proteins. The spots
representing Ctsk, Mpo, Lamp1, Lamp2, Neu1 and Ctsf are highlighted.
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low (Table I). The quantitative analysis revealed a high dy-
namic range of more than two orders of magnitude in the
average amounts of the different lysosomal protein species in
wt mice. The most abundant proteins were granulin (Grn; 23
pg/ng tritosome protein), recently assigned to be localized in
lysosomes (43), prosaposin (Psap; 19 g/g tritosome protein),
followed by cathepsin D (Ctsd; 18 g/g), -glucosidase (Gaa;
14 g/g), and -mannosidase (Man2b1; 13 g/g). The lowest
amounts of lysosomal proteins were measured for cathepsin
K (Ctsk), iduronate-2 sulfatase (Ids) and arylsulfatase G (Arsg),
ranging between 130 and 200 ng/g tritosome protein.
The levels of only five soluble lysosomal proteins in PTki
tritosomes were found to be lower than 50% in PTki in com-
parison with wt tritosomes. This subset includes neuramini-
dase 1 (Neu1), cathepsin F (Ctsf), Niemann Pick type C 2
protein (Npc2), cathepsin L1 (Ctsl), and sphingomyelin phos-
phodiesterase 1 (Smpd1). A number of additional proteins
showed significant, but less pronounced decrease in PTki
lysosomes. The majority of lysosomal proteins showed no or
only marginal differences in their concentration in tritosomes
between wt and PTki mice. Surprisingly, the level of 13 lyso-
somal proteins was increased in tritosomes of PTki mice. This
was most striking for cathepsin K (Ctsk) (1400%, p  4.35 
104). In addition to these established lysosomal proteins, we
identified a number of soluble proteins, for which a lysosomal
residency was suggested (42, 44). These include e.g. biotini-
dase, plasma -L-fucosidase, serum amyloid P-component,
or ribonuclease UK114 (supplemental Table S2). However, the
levels of none of them were significantly affected in PTki mice.
Abundant lysosomal membrane proteins like Lamp1,
Lamp2, Limp2, and Npc1 showed no differences in their total
levels in tritosomes between wt and PTki mice (Table I, sup-
plemental Table S3). A total of 45 known and 33 putative
lysosomal membrane proteins (supplemental Table S3 and
S4), identified previously in tritosomes (45), were detected
and quantified. Additional 64 proteins known to function in
endosomal and lysosomal trafficking processes were covered
by our proteomic analysis (supplemental Table S5).
Expression Levels of Lysosomal Proteins—In order to vali-
date our lysosomal proteomic dataset, we examined the ex-
pression of soluble lysosomal proteins and enzymes by West-
ern blotting and enzyme activity assays. As shown in Fig. 3
the amount of immunoreactive polypeptides Neu1, Npc2,
Ctsl, Ctsh, and Ctsa were significantly reduced in tritosomes
of PTki mice. The expression of Ctsb, Ctsd, Ctsz, and -glu-
curonidase (Gusb), as well as the lysosomal membrane pro-
tein Lamp1, were not or only marginally affected. Of note, for
Ctsb and Ctsd changes in the proportion of single chain (sc),
and their cleaved heavy (hc) and light chain (lc) forms were
observed. The relative amounts of Ctss was elevated in PTki
tritosomes in comparison to wt fractions (Fig. 3). The data for
these selected lysosomal proteins were in complete agree-
ment with the MS data analysis (Table I). For a number of
lysosomal enzymes we additionally determined the specific
activity in extracts of both liver tissue and tritosomes. Both
iduronate 2-sulfatase (Ids) and Fuca1 activities were 2- to
3-fold higher in liver tissue as well as tritosomes of Ptki mice
than of wt animals (Fig. 4A) corresponding to the increased
protein level of these enzymes. No significant changes where
observed for Gusb and Idua (Fig. 4A). No or only modest
changes in the mRNA levels of Npc2, Idua, Fuca1, Ctsk,
Neu1, Ctsf, and Ids were observed in liver tissue (supplemen-
tal Fig. S3A) whereas the respective lysosomal proteins were
increased or decreased, respectively, in tritosomes of PTki
mice (Table I). These data excluded transcriptional regulation
rather than posttranslational sorting events to explain the
different concentrations of these lysosomal proteins in lyso-
somal fractions, which might be representative for the other
lysosomal components. Western blotting analyses of whole
liver lysates generally resembled the protein expression level
in purified lysosomes, indicating that the bulk of these pro-
teins are found in lysosomes (supplemental Fig. S3B).
Distribution of Lysosomal Proteases in Liver Tissue—To
evaluate whether the almost unchanged concentrations of the
lysosomal proteases Ctsd, Ctsb, and Ctsz in liver tissue or
tritosomes between wt and PTki mice are caused by differen-
tial distribution in parenchymal cells (hepatocytes) and non-
parenchymal cells (Kupffer cells, stellate cells, liver sinusoid
endothelial cells (LSECs)), we performed immunofluores-
cence staining on liver sections. Ctsd, Ctsz, and Ctsb were
found to be colocalized with the lysosomal marker protein
Lamp1 both in wt and PTki hepatocytes representing the
major cell type in liver tissue (Fig. 4B). Ctsl, however, that was
reduced in PTki tritosomes to 40% of wt fractions, was almost
absent in PTki hepatocytes but expressed in nonparenchymal
cells (Fig. 4B).
Cultured Hepatic Cells—To examine differences in the
composition of lysosomes between wt and PTki on the cellular
level in more detail, we analyzed the steady state concentra-
tion, transport and sorting efficiency, and lysosomal localiza-
tion of selected soluble lysosomal proteins in cultured hepa-
tocytes and LSECs. Western blotting analysis revealed the
almost complete loss of mature Npc2 from PTki hepatocytes,
and the concomitant accumulation of Npc2 precursor poly-
peptides in the medium (Fig. 5A). Surprisingly, no accumula-
tion of filipin-positive nonesterified cholesterol was observed
in PTki hepatocytes (supplemental Fig. S4A) suggesting that
the residual amounts of Npc2 are sufficient to mediate the
egress of lipoprotein-derived cholesterol from lysosomes.
Similarly, to the tritosome data, the steady state concentration
of Neu1 was strongly reduced in PTki hepatocytes, whereas
comparable amounts of Ctsb and Ctsz were found in hepa-
tocytes of both genotypes. Different proteolytically processed
forms of Ctsl and Ctsd were observed in wt and PTki hepa-
tocytes. The latter lack the 20 kDa mature Ctsl form and
exhibit a distinct proteolytic processing of single chain
and heavy chain Ctsd forms. For both Ctsl (short exposure)
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TABLE I
List of soluble and selected lysosomal membrane proteins identified in wt and PTki liver lysosomes
Proteins known to be components of lysosomes (41, 44) are given. The total levels for each protein in g/g tritosome protein is the average
of n  4. The fold change is given as the ratio between the mean PTki/wt. ns  not significant, p  0.05  *; p  0.01  **; p  0.001  ***.
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and Ctsd increased amounts of missorted precursor forms
were detected in the medium (Fig. 5A).
To analyze targeting, sorting and processing of Ctsd and
Ctsz in hepatocytes in more detail, [35S] methionine pulse-
chase experiments were performed. The rate of synthesis of
Ctsd and Ctsz was comparable in wt and PTki hepatocytes
(Fig. 5B, lane 1 and 3). During the chase period proteolytic
maturation of newly synthesized Ctsd was impaired in PTki
hepatocytes, and only a small portion was retained intracel-
lularly accompanied by hypersecretion of the precursor form
(Fig. 5B, lane 4 and 6). During the chase Ctsz was completely
missorted by PTki hepatocytes into the medium (Fig. 5B, lane
4 and 6). The presence of other lysosomal enzymes, -L-
fucosidase, -glucuronidase, and -L-iduronidase, were de-
tected by measurement of their enzymatic activity in hepato-
cyte extracts and conditioned medium. Similar activities of
these lysosomal hydrolases were detected in wt and PTki
hepatocytes with the exception of -L-fucosidase that was
FIG. 3. Analysis of lysosomal proteins that are specifically changed in their expression in PTki lysosomes. Western blotting analysis for
Neu1, Npc2, Ctsl, Ctsh, Ctsa, Ctsb, Ctsd, Ctsz, Gusb, Ctss, and Lamp1 in lysosome-enriched fractions from wt and PTki mice. Densitometric
evaluation of the corresponding immunoreactive bands confirms the significant differences between wt and PTki samples (n  4; sc, single
chain; hc, heavy chain; lc, light chain; ns, not significant; p  0.05, *; p  0.01, **; p  0.001, ***).
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increased both in cells and the medium (supplemental Fig.
S4B). Double immunofluorescence microscopic imaging re-
vealed the prominent expression of Ctsd, Ctsb and Neu1 in
Lamp 1-positive structures of wt and PTki hepatocytes (Fig.
5C). These data were supported by Western blotting analyses
of lysosomal proteins in cultured LSECs. The expression pat-
tern of Neu1, Npc2, Ctsb, and Ctsz appear to be similar of
those in cultured hepatocytes (supplemental Fig. S5). In con-
trast, the amounts and the proteolytic processing of Ctsl and
Ctsd in PTki LSECs differed from cultured PTki hepatocytes,
FIG. 4. Enzymatic activity and local-
ization of lysosomal enzymes in PTki
liver. A, The relative enzyme activities of
iduronate-2-sulfatase, -glucuronidase,
-L-iduronidase and -L-fucosidase
were measured in liver lysates and lyso-
some-enriched fractions (tritosomes).
The specific activities of wt were set to 1.
ns, not significant; p  0.05, *; p  0.01,
**; p  0.001, ***. B, Immunofluorescence
staining of lysosomal proteins on liver
sections. Coimmunofluorescence stain-
ing on liver sections show that Ctsd, Ctsb
and Ctsz (red) are mainly found in Lamp2-
positive structures (green) in both hepato-
cytes and nonparenchymal, whereas Ctsl
is significantly reduced in PTki hepato-
cytes. For each panel, a hepatocyte (with
large round nucleus) is shown in an en-
larged inset. Nuclei were stained with
DAPI (blue). Scale bars: 25 m.
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and were rather similar to those in wt cells. Together, the
expression, targeting efficiency and lysosomal localization of
the most soluble lysosomal proteins tested in isolated primary
hepatic cells or LSECs resemble their MS-based quantity and
immuno-positive expression in tritosome fractions of wt and
PTki mice.
Cargo Receptors—The majority of soluble lysosomal pro-
teins in PTki tritosomes were found in comparable amounts as
in wt controls suggesting their M6P-independent transport.
Because it has been shown that in PTki fibroblasts Lrp1 and
LDL receptors (Ldlr) are involved in M6P-independent target-
ing of nonphosphorylated lysosomal proteins (31), we have
analyzed the expression of known and potential cargo recep-
tors. No differences in the expression of Lrp1 protein have
been observed in tritosome fractions, liver lysate or cultured
hepatocytes between PTki and wt controls (supplemental Fig.
S6A and S6B). Of note, there is an accumulation of Lrp1
fragments in PTki tritosomes. In cultured hepatocytes the
amount of the Ldlr was increased most likely because of
increased transcriptional activation (supplemental Fig. S6B
and S6C). The total amounts of Mpr300 in PTki hepatocytes
are not altered and corresponded with the relative mRNA
expression level (supplemental Fig. S6B and S6C). However,
the 1.8-fold higher amount of the internalized recombinant
M6P-containing Mpr300 ligand, [125I] arylsulfatase B (ARSB),
indicated that the number of Mpr300 localized at the surface
of PTki hepatocytes is increased (supplemental Fig. S6D).
DISCUSSION
This study reports on the first quantitative analysis of the
lysosomal proteome of mouse liver recovering almost all
known soluble lysosomal enzymes and accessory proteins.
These data were compared with the lysosomal proteome from
mice lacking the lysosomal targeting signal mannose 6-phos-
FIG. 5. Sorting, transport and localization of lysosomal proteins in cultured PTki hepatocytes. A, Isolated hepatocytes from wt and PTki
mice were cultivated for 2 days and the expression of Neu1, Npc2, Ctsl, Ctsb, Ctsd, Ctsz and Lamp1 were determined by Western blotting
in the cell lysates and conditioned media. The ER marker protein disulfide isomerase (Pdi) was used as loading control. All soluble lysosomal
proteins are missorted to variable degree indicated by reduced intracellular levels and increased secretion into the medium. The intracellular
retention of Ctsl, Ctsb and Ctsd are less affected. Comparable Lamp1 levels between wt and PTki cells are observed. B, Hepatocytes from wt
and PTki mice were labeled with [35S]-methioine for 45 min and either harvested (, lanes 1, 3) or chased for 5 h (, lanes 2, 4) followed by
immunoprecipitation of cathepsin D (Ctsd) and cathepsin Z (Ctsz) from cell extracts (lanes 1–4) and media (lanes 5–6). The immunocomplexes
were solubilized, separated by SDS-PAGE and visualized by fluorography. Secretion of newly synthesized Ctsd and Ctsz is increased in PTki
hepatocytes, accompanied by a significant reduction or complete loss of processed intracellular mature forms, respectively, during the chase.
C, Isolated hepatocytes from wt and PTki mice were fixed, and immunostained for localization of endogenous cathepsin D (Ctsd), cathepsin
B (Ctsb) and neuraminidase 1 (Neu1) in red and the lysosomal marker protein Lamp1 (green). Nuclei were stained with DAPI (blue). Only merged
images are shown in which yellow indicates colocalization of the antigens. Magnified images of the indicated white rectangles are shown in the
insets. Scale bars: 7.5 m.
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phate (M6P), and provided valuable insights into i) the effi-
ciency of alternate transport systems in liver cells to prevent
lysosomal dysfunctions, and ii) peripheral proteins attached
transiently to the cytosolic surface of lysosomes playing an
important role in lysosomal positioning, fusion, and signaling.
Our approach also extended previous studies combining affinity
purification of M6P-containing proteins with mass spectrometry
of several tissues and lysosomal disease models (46–48) which
neither allow quantitative analyses of lysosomal proteomes nor
its application to cells or tissues of mucolipidosis II patients or
corresponding mouse models, respectively.
The concentrations of the identified 67 known soluble lys-
osomal proteins comprising different classes of acidic hydro-
lases and accessory proteins vary over a wide range from
highly abundant cathepsin D and granulin (334 and 342
nmoles/g lysosomal protein, respectively), to low abundant
-L fucosidase, iduronate 2-sulfatase, and cathepsin K (4.0, 2.1,
and 2 nmoles/g, respectively). Similarly, the lysosomal integral
membrane proteins Npc1, Lamp1, and Limp2 (Scarb2) repre-
sent highly abundant proteins (202, 105, and 158 nmoles/g
lysosomal protein, respectively) whereas others, such as the
osteopetrosis-associated transmembrane protein 1 (Ostm1),
phosphatidylinositol 4,5 bisphosphate 4-phosphatase (TM55A),
and presenilin1 belong to the low expressed proteins (3.7, 2.1,
and 1.3 nmoles/g lysosomal protein, respectively).
Furthermore, our approach allowed the quantification of
steady-state concentrations of peripheral membrane proteins
on the cytoplasmic side of lysosomes involved in vesicular
targeting, positioning, and signaling. Among the numerous
proteins playing a role in the vesicular transport machinery
(supplemental Table S5), the adaptor protein AP3 complex
subunits comprised the most abundant proteins (17.4–31.7
nmoles/g lysosomal protein). In addition, five of the eight
subunits of the BLOC-one-related complex (BORC) essential
for lysosome positioning (49) have been identified in our prep-
arations. Their expression ranges from 1.1 nmoles (Mef2bnb)
to 6.2 nmoles/g lysosomal protein (myrlysin). In addition,
rab7a and Arl8b, which have been recently reported to be
involved in redistribution of lysosomes (50), belong to the
more abundant peripheral proteins (11.7 and 24.2 nmoles/g
lysosomal protein). Finally, we found all five Ragulator sub-
units LAMTOR 1 to 5 (Lysosomal Adaptor and Mitogen-acti-
vated protein kinase and mTOR activator/regulator) which
interact with and recruit Rag GTPases to the lysosomal sur-
face and mediate the translocation and activation of mTOR
complex 1 (51). mTORC1 is a central component of fine tuned
signaling pathways coupling internal and external stimuli (52).
The primary biochemical defect in ML II is the lack in
GlcNAc-1-phosphotransferase (PT) activity that causes the
inability to generate the M6P recognition marker for efficient
targeting of soluble lysosomal enzymes. Therefore, fibroblasts
and mesenchymal cells are deficient for a large number of
lysosomal enzymes because of their hypersecretion (53).
However, in certain liver cells of ML II patients such as hepa-
tocytes or Kupffer cells, and in liver tissue of patients and PTki
mice nearly normal levels of few selected lysosomal enzymes
were reported (17, 19, 20). In agreement with these observa-
tions, our quantitative analysis of the lysosomal proteome
revealed that the concentration of only 5 out of 67 soluble
proteins (Neu1, Ctsf, Npc2, Ctsl, and Smpd1) were more than
50% reduced in comparison with wild-type proteins (Table I)
independent of transcriptional regulation (supplemental Fig.
S3A). The proteome data were validated by Western blotting
analyses of 11 soluble lysosomal enzymes in tritosome frac-
tions (Fig. 3) and by activity measurements of four additional
lysosomal enzymes (Fig. 4A). The low amounts of neuramin-
idase 1 (Neu1, sialidase) might lead to increased excretion of
sialic acid-containing oligosaccharides in the urine as de-
scribed in ML II patients (54). The loss of neuraminidase 1
from lysosomes is, however, far more severe in fibroblasts,
where no activity of neuraminidase 1 in fibroblasts of three
unrelated ML II patients was found (55). This has been con-
firmed by SILAC-based lysosomal proteome analysis of PTki
mouse fibroblasts that found 5% neuraminidase 1 protein
compared with wild-type controls (31). It is obvious, however,
that the partial loss of a few select lysosomal enzymes is not
limiting for lysosome functions as demonstrated by the ab-
sence of storage material in PTki liver sections by electron
microscopy (supplemental Fig. S7) that is also supported by
our results in cultured hepatocytes (Fig. 5 and supplemental
Fig. S4) and liver sinusoid endothelial cells (supplemental Fig.
S5) prepared from wild-type and PTki mice. The majority (49 of
67) of luminal (Table I), integral and peripheral lysosomal
proteins were not or only moderately changed in their con-
centration in PTki lysosomal fractions (supplemental Tables
S3 and S5).
The nearly normal composition of luminal proteins in liver
lysosomes in the absence of M6P residues suggests that
there are alternate M6P-independent targeting systems to
lysosomes. Several M6P-independent receptors for the trans-
port of lysosomal enzymes have been identified such as the
LDL receptor-related protein 1 (Lrp1; (31, 43, 56, 57)), Lrp2
(megalin;(58)), LIMP-2 (59), Sortilin (60–62), SEZ6L2 (63), and
mannose receptors (64). For the majority of these alternate
M6P-independent receptors one or only a few lysosomal en-
zyme ligands have been tested or verified. Therefore it is unclear
how many different receptor routes are used in liver cells of PTki
mice in vivo to allow the targeting of the 60 lysosomal en-
zymes. At least in part, the acid hydrolases secreted by all cells
of PTki mice are cleared from the plasma by mannose receptors
localized on macrophage-like Kupffer cells and hepatic endo-
thelial cells (64) and exhibiting specificities for terminal man-
nose, GlcNAc and fucose residues (65). Additionally, the high
number of LDL receptor and Lrp1 on the surface of hepatocytes
most likely contribute to the re-internalization of missorted, non-
phosphorylated lysosomal enzymes (31).
In summary, our lysosomal proteome analyses reveal strik-
ing protein-specific differences in the abundance of soluble
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and membrane-bound proteins as well as in peripheral pro-
teins localized on the cytosolic side of mouse liver lysosomes.
The lysosomal composition and the lack of storage material in
liver unable to form the major lysosomal targeting signal,
mannose 6-phosphate, suggests that alternate cargo recep-
tor routes guarantee the transport of nonphosphorylated lys-
osomal enzymes in sufficient amounts to maintain almost
normal functions of liver cells. These observations emphasize
that the lysosomal proteome must be quantified systemati-
cally in various organs and cell types in order to further our
understanding of the physiological role of individual and sub-
sets of lysosomal enzymes in cellular homeostasis.
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